These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17210730)

  • 1. Igkappa allelic inclusion is a consequence of receptor editing.
    Casellas R; Zhang Q; Zheng NY; Mathias MD; Smith K; Wilson PC
    J Exp Med; 2007 Jan; 204(1):153-60. PubMed ID: 17210730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic and isotypic light chain inclusion in peripheral B cells from anti-DNA antibody transgenic C57BL/6 and BALB/c mice.
    Witsch EJ; Bettelheim E
    J Immunol; 2008 Mar; 180(6):3708-18. PubMed ID: 18322176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of receptor editing to the antibody repertoire.
    Casellas R; Shih TA; Kleinewietfeld M; Rakonjac J; Nemazee D; Rajewsky K; Nussenzweig MC
    Science; 2001 Feb; 291(5508):1541-4. PubMed ID: 11222858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models for antigen receptor gene rearrangement. III. Heavy and light chain allelic exclusion.
    Kalmanovich G; Mehr R
    J Immunol; 2003 Jan; 170(1):182-93. PubMed ID: 12496399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models for antigen receptor gene rearrangement. I. Biased receptor editing in B cells: implications for allelic exclusion.
    Mehr R; Shannon M; Litwin S
    J Immunol; 1999 Aug; 163(4):1793-8. PubMed ID: 10438911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced kappa receptor editing shows no allelic preference in a mouse pre-B cell line.
    Liu X; Linden M; Van Ness B
    J Immunol; 2000 Dec; 165(12):7058-63. PubMed ID: 11120834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
    Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
    J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens.
    Liu S; Velez MG; Humann J; Rowland S; Conrad FJ; Halverson R; Torres RM; Pelanda R
    J Immunol; 2005 Oct; 175(8):5067-76. PubMed ID: 16210610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
    Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
    Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance.
    Prak EL; Trounstine M; Huszar D; Weigert M
    J Exp Med; 1994 Nov; 180(5):1805-15. PubMed ID: 7964462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor editing and genetic variability in human autoreactive B cells.
    Lang J; Ota T; Kelly M; Strauch P; Freed BM; Torres RM; Nemazee D; Pelanda R
    J Exp Med; 2016 Jan; 213(1):93-108. PubMed ID: 26694971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ataxia telangiectasia mutated kinase controls Igκ allelic exclusion by inhibiting secondary Vκ-to-Jκ rearrangements.
    Steinel NC; Lee BS; Tubbs AT; Bednarski JJ; Schulte E; Yang-Iott KS; Schatz DG; Sleckman BP; Bassing CH
    J Exp Med; 2013 Feb; 210(2):233-9. PubMed ID: 23382544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig.
    Brady GF; Congdon KL; Clark AG; Sackey FN; Rudolph EH; Radic MZ; Foster MH
    J Immunol; 2004 May; 172(9):5313-21. PubMed ID: 15100270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell receptor editing in tolerance and autoimmunity.
    Azulay-Debby H; Melamed D
    Front Biosci; 2007 Jan; 12():2136-47. PubMed ID: 17127450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ig light chain receptor editing in anergic B cells.
    Tze LE; Baness EA; Hippen KL; Behrens TW
    J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual immunoglobulin light chain B cells: Trojan horses of autoimmunity?
    Pelanda R
    Curr Opin Immunol; 2014 Apr; 27():53-9. PubMed ID: 24549093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating human B cells that express surrogate light chains and edited receptors.
    Meffre E; Davis E; Schiff C; Cunningham-Rundles C; Ivashkiv LB; Staudt LM; Young JW; Nussenzweig MC
    Nat Immunol; 2000 Sep; 1(3):207-13. PubMed ID: 10973277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance-induced receptor selection: scope, sensitivity, locus specificity, and relationship to lymphocyte-positive selection.
    Aït-Azzouzene D; Skog P; Retter M; Kouskoff V; Hertz M; Lang J; Kench J; Chumley M; Melamed D; Sudaria J; Gavin A; Martensson A; Verkoczy L; Duong B; Vela J; Nemazee D; Alfonso C
    Immunol Rev; 2004 Feb; 197():219-30. PubMed ID: 14962198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VprBP Is Required for Efficient Editing and Selection of Igκ+ B Cells, but Is Dispensable for Igλ+ and Marginal Zone B Cell Maturation and Selection.
    Palmer VL; Aziz-Seible R; Kassmeier MD; Rothermund M; Perry GA; Swanson PC
    J Immunol; 2015 Aug; 195(4):1524-37. PubMed ID: 26150531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.